TARS NASDAQ
Tarsus Pharmaceuticals, Inc.
1W: -3.5%
1M: -11.8%
3M: +8.9%
YTD: -9.6%
1Y: +27.3%
3Y: +362.3%
5Y: +220.5%
$73.00
-2.46 (-3.26%)
Weekly Expected Move ±7.1%
$63
$68
$73
$78
$83
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
ESG Scores — TARS
Company vs Sector Average
Historical ESG Trend
View All ESG Filings (20)
| Date | Form | Environmental | Social | Governance | ESG Score | Filing |
|---|---|---|---|---|---|---|
| 2026-06-30 | 10-Q | 57.1 | 63.6 | 58.6 | 59.8 | SEC ↗ |
| 2026-03-31 | 10-Q | 57.1 | 62.8 | 58.0 | 59.3 | SEC ↗ |
| 2025-12-31 | 10-K | 58.2 | 63.4 | 58.4 | 60.0 | SEC ↗ |
| 2025-09-30 | 10-Q | 58.0 | 63.0 | 58.6 | 59.9 | SEC ↗ |
| 2025-06-30 | 10-Q | 57.6 | 63.3 | 58.5 | 59.8 | SEC ↗ |
| 2025-03-31 | 10-Q | 57.1 | 62.8 | 58.2 | 59.4 | SEC ↗ |
| 2024-12-31 | 10-K | 57.8 | 63.5 | 58.8 | 60.0 | SEC ↗ |
| 2024-09-30 | 10-Q | 57.9 | 65.3 | 60.0 | 61.1 | SEC ↗ |
| 2024-06-30 | 10-Q | 57.4 | 64.7 | 59.4 | 60.5 | SEC ↗ |
| 2024-03-31 | 10-Q | 56.8 | 64.2 | 59.0 | 60.0 | SEC ↗ |
| 2023-12-31 | 10-K | 57.0 | 63.6 | 60.3 | 60.3 | SEC ↗ |
| 2023-09-30 | 10-Q | 68.2 | 69.5 | 67.5 | 68.4 | SEC ↗ |
| 2023-06-30 | 10-Q | 72.6 | 71.8 | 73.1 | 72.5 | SEC ↗ |
| 2023-03-31 | 10-Q | 67.8 | 69.1 | 70.5 | 69.1 | SEC ↗ |
| 2022-12-31 | 10-K | 56.9 | 64.1 | 61.4 | 60.8 | SEC ↗ |
| 2022-09-30 | 10-Q | 68.6 | 72.6 | 72.0 | 71.1 | SEC ↗ |
| 2022-06-30 | 10-Q | 66.5 | 73.4 | 70.7 | 70.2 | SEC ↗ |
| 2021-12-31 | 10-K | 57.8 | 65.7 | 61.9 | 61.8 | SEC ↗ |
| 2021-09-30 | 10-Q | 69.9 | 71.2 | 73.6 | 71.5 | SEC ↗ |
| 2020-12-31 | 10-K | 57.7 | 65.8 | 63.7 | 62.4 | SEC ↗ |